Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.

The trial, which will involve around 350 patients with reduced ejection fraction, will begin enrolling in early 2025.

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

Pulsed field ablation (PFA) is emerging as an alternative, using non-thermal electric fields to target cardiac tissue while ...

Chuck's cycling journey living with AFib, from diagnosis to catheter ablation to recovery, read about living and riding with ...